Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4748)
All Articles published online
|
Jul 28, 2007 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Field K, Lipton L. Metastatic colorectal cancer-past, progress and future. World J Gastroenterol 2007; 13(28): 3806-3815 [PMID: 17657834 DOI: 10.3748/wjg.v13.i28.3806] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i28/3806.htm |
| Number | Citing Articles |
| 1 |
Francis Park-Yun Cheung, Naveed Zeb Alam, Gavin Michael Wright. The Past, Present and Future of Pulmonary Metastasectomy: A Review Article. Annals of Thoracic and Cardiovascular Surgery 2019; 25(3): 129 doi: 10.5761/atcs.ra.18-00229
|
| 2 |
Woo-Jeong Jeong, Pu-Hyeon Cha, Kang-Yell Choi. Strategies to overcome resistance to epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancer. World Journal of Gastroenterology 2014; 20(29): 9862-9871 doi: 10.3748/wjg.v20.i29.9862
|
| 3 |
Omar Castillo-Fernández, Miguel Santibáñez, Aldo Bauza, Germán Calderillo, Clementina Castro, Roberto Herrera, Alberto Serrano, Oscar Arrieta, Luis A. Herrera. Methylenetetrahydrofolate Reductase Polymorphism (677 C>T) Predicts Long Time to Progression in Metastatic Colon Cancer Treated with 5-Fluorouracil and Folinic Acid. Archives of Medical Research 2010; 41(6): 430 doi: 10.1016/j.arcmed.2010.08.011
|
| 4 |
Ning Wang, Liyi Zeng, Zhaoxia Li, Yanfang Zhen, Huoming Chen.
Serum
miR-663
expression and the diagnostic value in colorectal cancer
. Artificial Cells, Nanomedicine, and Biotechnology 2019; 47(1): 2650 doi: 10.1080/21691401.2019.1628036
|
| 5 |
Yoko Tomita, Christos S. Karapetis, Shahid Ullah, Amanda R. Townsend, David Roder, Carol Beeke, Amitesh C. Roy, Rob Padbury, Timothy J. Price. Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry. Acta Oncologica 2016; 55(4): 480 doi: 10.3109/0284186X.2015.1117135
|
| 6 |
Nami Sato, Nozomu Sakai, Katsunori Furukawa, Tsukasa Takayashiki, Satoshi Kuboki, Shigetsugu Takano, Gaku Ohira, Hisahiro Matsubara, Masayuki Ohtsuka. Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer. Oncology Reports 2022; 47(5) doi: 10.3892/or.2022.8298
|
| 7 |
Xing‐Hua Liang, Guang‐Xian Zhang, Yue‐bin Zeng, Hai‐Feng Yang, Wen‐Hong Li, Qi‐Long Liu, Yue‐liang Tang, Wen‐guang He, Yan‐Nian Huang, Lei Zhang, Li‐Na Yu, Xian‐Cheng Zeng. LIM protein JUB promotes epithelial–mesenchymal transition in colorectal cancer. Cancer Science 2014; 105(6): 660 doi: 10.1111/cas.12404
|
| 8 |
Elena A. Pudova, Anna V. Kudryavtseva, Maria S. Fedorova, Andrew R. Zaretsky, Dmitry S. Shcherbo, Elena N. Lukyanova, Anatoly Y. Popov, Asiya F. Sadritdinova, Ivan S. Abramov, Sergey L. Kharitonov, George S. Krasnov, Kseniya M. Klimina, Nadezhda V. Koroban, Nadezhda N. Volchenko, Kirill M. Nyushko, Nataliya V. Melnikova, Maria A. Chernichenko, Dmitry V. Sidorov, Boris Y. Alekseev, Marina V. Kiseleva, Andrey D. Kaprin, Alexey A. Dmitriev, Anastasiya V. Snezhkina. HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer. BMC Genomics 2018; 19(S3) doi: 10.1186/s12864-018-4477-4
|
| 9 |
Kimmie Ng, Josep Tabernero, Jimmy Hwang, Emilio Bajetta, Sunil Sharma, Salvatore A. Del Prete, Edward R. Arrowsmith, David P. Ryan, Michaela Sedova, Jin Jin, Kamel Malek, Charles S. Fuchs. Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens. Clinical Cancer Research 2013; 19(14): 3987 doi: 10.1158/1078-0432.CCR-13-0027
|
| 10 |
Li-Jun Wang, Zhong-Yi Zhang, Xiao-Luan Yan, Wei Yang, Kun Yan, Bao-Cai Xing. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis. World Journal of Surgical Oncology 2018; 16(1) doi: 10.1186/s12957-018-1494-3
|
| 11 |
Alessandra Silvestri, Valerie Calvert, Claudio Belluco, Michael Lipsky, Ruggero De Maria, Jianghong Deng, Alfonso Colombatti, Francesco De Marchi, Donato Nitti, Enzo Mammano, Lance Liotta, Emanuel Petricoin, Mariaelena Pierobon. Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations. Clinical & Experimental Metastasis 2013; 30(3): 309 doi: 10.1007/s10585-012-9538-5
|
| 12 |
Seyed Khalil Rashidi, Seyed Latif Mousavi Gargari, Walead Ebrahimizadeh. Targeting Colorectal Cancer Cell Lines Using Nanobodies; AgSK1as a Potential Target. Iranian Journal of Biotechnology 2017; 15(2): 78 doi: 10.15171/ijb.1472
|
| 13 |
Xiaochuan Liu, Yunxiang Chu, Dongsheng Wang, Yan Weng, Zhiwei Jia. MAPK‐mediated upregulation of fibrinogen‐like protein 2 promotes proliferation, migration, and invasion of colorectal cancer cells. Cell Biology International 2019; 43(12): 1483 doi: 10.1002/cbin.11198
|
| 14 |
Nele Boeckx, Ken Op de Beeck, Vanessa Deschoolmeester, Guy Van Camp, Patrick Pauwels, Marc Peeters. Anti-EGFR Resistance in Colorectal Cancer: Current Knowledge and Future Perspectives. Current Colorectal Cancer Reports 2014; 10(4): 380 doi: 10.1007/s11888-014-0242-5
|
| 15 |
Tai-Lin Chen, Yi-Wen Lin, Yan-Bo Chen, Jing-Jer Lin, Tsann-Long Su, Chia-Ning Shen, Te-Chang Lee. A Low-Toxicity DNA-Alkylating N-Mustard-Quinoline Conjugate with Preferential Sequence Specificity Exerts Potent Antitumor Activity Against Colorectal Cancer. Neoplasia 2018; 20(2): 119 doi: 10.1016/j.neo.2017.11.006
|
| 16 |
JaeIn Park, Jae-Hyun Jang, Jae-Hong Kim. Mediatory role of BLT2 in the proliferation of KRAS mutant colorectal cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2019; 1866(3): 329 doi: 10.1016/j.bbamcr.2018.12.006
|
| 17 |
Nasrin Sarafan-Vasseur, David Sefrioui, David Tougeron, Aude Lamy, France Blanchard, Florence Le Pessot, Frédéric Di Fiore, Pierre Michel, Stéphane Bézieau, Jean-Baptiste Latouche, Thierry Frebourg, Richard Sesboüé. Genetic variations of the A13/A14 repeat located within the EGFR3′ untranslated region have no oncogenic effect in patients with colorectal cancer. BMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-183
|
| 18 |
S.D. Richman, G.G.A. Hutchins, M.T. Seymour, P. Quirke. What can the molecular pathologist offer for optimal decision making?. Annals of Oncology 2010; 21: vii123 doi: 10.1093/annonc/mdq379
|
| 19 |
Ghodratollah Roshanaei, Malihe Safari, Javad Faradmal, Mohammad Abbasi, Salman Khazaei. Factors affecting the survival of patients with colorectal cancer using random survival forest. Journal of Gastrointestinal Cancer 2022; 53(1): 64 doi: 10.1007/s12029-020-00544-3
|
| 20 |
Jong Min Lee, Yoon Dae Han, Min Soo Cho, Hyuk Hur, Kang Young Lee, Nam Kyu Kim, Byung Soh Min. Neoadjuvant chemotherapy versus upfront surgery as the initial treatment for patients with resectable, synchronous colorectal cancer liver metastases. Journal of Surgical Oncology 2023; 128(4): 549 doi: 10.1002/jso.27308
|
| 21 |
Yikuan Chen, Shaobo Mo, Mengdi Wu, Yaqi Li, Xi Chen, Junjie Peng. Circulating tumor DNA as a prognostic indicator of colorectal cancer recurrence—a systematic review and meta-analysis. International Journal of Colorectal Disease 2022; 37(5): 1021 doi: 10.1007/s00384-022-04144-4
|
| 22 |
Qiuji Wu, Pengfei Zhang, Xinyuan Wang, Mengxi Zhang, Weiting Liao, Qiu Li. Cost-effectiveness of Capecitabine + Irinotecan Versus Leucovorin + Fluorouracil + Irinotecan in the Second-line Treatment of Metastatic Colorectal Cancer in China. Clinical Therapeutics 2020; 42(11): 2148 doi: 10.1016/j.clinthera.2020.08.015
|
| 23 |
Fabian Frank, Markus Hecht, Florian Loy, Sandra Rutzner, Rainer Fietkau, Luitpold Distel. Differences in and Prognostic Value of Quality of Life Data in Rectal Cancer Patients with and without Distant Metastases. Healthcare 2020; 9(1): 1 doi: 10.3390/healthcare9010001
|
| 24 |
Dinuk Goonerante, Chris Gray, Michael Lim, Liane Dixon, Bruce Dobbs, Chris Wakeman, Frank Frizelle. Survival outcome in New Zealand after resection of colorectal cancer lung metastases. ANZ Journal of Surgery 2013; 83(12): 959 doi: 10.1111/ans.12012
|
| 25 |
Md Shuayb, Md Mehedi Hasan, Md Rashedul Hoque, Qazi Mushtaq Hussain, Rabeya Begum, Md Salim Reza. Survival and prognostic association in stage IV colorectal cancer patients treated with chemotherapy in Bangladesh. Japanese Journal of Clinical Oncology 2021; 51(4): 552 doi: 10.1093/jjco/hyaa228
|
| 26 |
Chenbo Ding, Junmin Luo, Longmei Li, Shanshan Li, Liwen Yang, Hongfei Pan, Qianyi Liu, Huan Qin, Chao Chen, Jihong Feng. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer. Journal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-015-0280-0
|
| 27 |
Seo Hee Choi, Gowoon Yang, Woong Sub Koom, Seung Yoon Yang, Seung‐Seob Kim, Joon Seok Lim, Han Sang Kim, Sang Joon Shin, Jee Suk Chang. Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer. Cancer Medicine 2023; 12(22): 21057 doi: 10.1002/cam4.6667
|
| 28 |
Weili Miao, Yinsheng Wang. Targeted Quantitative Kinome Analysis Identifies PRPS2 as a Promoter for Colorectal Cancer Metastasis. Journal of Proteome Research 2019; 18(5): 2279 doi: 10.1021/acs.jproteome.9b00119
|
| 29 |
Urspeter Masche, Urs Strebel, Dominique H. Criblez, Urs Marbet, Markus M. Borner, Peter Buchmann, Richard Herrmann. Kolorektalkarzinom. pharma-kritik 2008; 30(3) doi: 10.37667/pk.2008.227
|
| 30 |
Min Yan, Ronghao Yang, Qi Li, Chenjie Wang, Jiali Chen, Zhenying Wu, Han Li, Juan Fan. Anti-angiogenic and antitumor effects of anlotinib combined with bevacizumab for colorectal cancer. Translational Oncology 2024; 41: 101887 doi: 10.1016/j.tranon.2024.101887
|
| 31 |
Albrecht Reichle. From Molecular to Modular Tumor Therapy. 2010; : 469 doi: 10.1007/978-90-481-9531-2_23
|
| 32 |
Young-Mi Lee, Saluja Kaduwal, Kug Hwa Lee, Jong-Chan Park, Woo-Jeong Jeong, Kang-Yell Choi. Sur8 mediates tumorigenesis and metastasis in colorectal cancer. Experimental & Molecular Medicine 2016; 48(7): e249 doi: 10.1038/emm.2016.58
|
| 33 |
Tomasz Olesinski, Joanna Milewska, Malgorzata Symonides, Jakub Palucki, Andrzej Mróz, Andrzej Rutkowski. Pancreatic Metastases of Rectal Cancer—Case Report and Literature Review. Journal of Gastrointestinal Cancer 2019; 50(2): 338 doi: 10.1007/s12029-017-0016-9
|
| 34 |
Leonie Harmse, Nadia Gangat, Carla Martins-Furness, Jean Dam, Charles B. de Koning. Copper-imidazo[1,2-a]pyridines induce intrinsic apoptosis and modulate the expression of mutated p53, haem-oxygenase-1 and apoptotic inhibitory proteins in HT-29 colorectal cancer cells. Apoptosis 2019; 24(7-8): 623 doi: 10.1007/s10495-019-01547-7
|
| 35 |
Leo Chen, Caroline H. Speers, Winson Y. Cheung, John J. Spinelli, Hagen F. Kennecke. Impact of new cancer therapies on outpatient treatment delivery for colorectal cancer: A population‐based study. The International Journal of Health Planning and Management 2022; 37(1): 258 doi: 10.1002/hpm.3308
|
| 36 |
Sadaf Qureshi, Lyudmyla Berim, Patrick M. Boland. Current Treatment Landscape for Third- or Later-Line Therapy in Metastatic Colorectal Cancer. Current Colorectal Cancer Reports 2021; 17(6): 131 doi: 10.1007/s11888-021-00469-4
|
| 37 |
Łukasz Pietrzyk, Paulina Wdowiak. Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patients. Advances in Medical Sciences 2019; 64(2): 402 doi: 10.1016/j.advms.2019.07.001
|
| 38 |
Duthika M. Mallawaaratchy, Swetlana Mactier, Kimberley L. Kaufman, Katherine Blomfield, Richard I. Christopherson. The phosphoinositide 3-kinase inhibitor LY294002, decreases aminoacyl-tRNA synthetases, chaperones and glycolytic enzymes in human HT-29 colorectal cancer cells. Journal of Proteomics 2012; 75(5): 1590 doi: 10.1016/j.jprot.2011.11.032
|
| 39 |
Kaitlyn J Kelly, Joyce Wong, Yuman Fong. Herpes simplex virus NV1020 as a novel and promising therapy for hepatic malignancy. Expert Opinion on Investigational Drugs 2008; 17(7): 1105 doi: 10.1517/13543784.17.7.1105
|
| 40 |
G. G. Khakimova, A. A. Tryakin, T. N. Zabotina, A. S. Tsukanov, V. A. Aliev, S. L. Gutorov. The Role of the Intestinal Microbiome in the Immunotherapy of Colon Cancer. Malignant tumours 2019; 9(2): 5 doi: 10.18027/2224-5057-2019-9-2-5-11
|
| 41 |
Alfonso De Stefano, Chiara Carlomagno. Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer. World Journal of Gastroenterology 2014; 20(29): 9732-9743 doi: 10.3748/wjg.v20.i29.9732
|
| 42 |
Nitu L. Wankhede, Mayur B. Kale, Ashwini K. Bawankule, Brijesh G. Taksande, Milind J. Umekar, Aman B. Upaganlawar. Colorectal Cancer. 2024; : 307 doi: 10.1016/B978-0-443-13870-6.00008-8
|
| 43 |
Ellen G. Engelhardt, Dóra Révész, Hans J. Tamminga, Cornelis J.A. Punt, Mirjam Koopman, Bregje D. Onwuteaka-Philipsen, Ewout W. Steyerberg, Ilse P. Jansma, Henrica C.W. De Vet, Veerle M.H. Coupé. Clinical Usefulness of Tools to Support Decision-making for Palliative Treatment of Metastatic Colorectal Cancer: A Systematic Review. Clinical Colorectal Cancer 2018; 17(1): e1 doi: 10.1016/j.clcc.2017.06.007
|
| 44 |
A. Silvestri, E. Pin, A. Huijbers, R. Pellicani, E. M. Parasido, M. Pierobon, E. Petricoin, L. Liotta, C. Belluco. Individualized therapy for metastatic colorectal cancer. Journal of Internal Medicine 2013; 274(1): 1 doi: 10.1111/joim.12070
|
| 45 |
Nedyalka Zgurova, Krasimira Prodanova, Maria Tzaneva, Janko Stefanov. Prognostic factors for the presence of the methastasis in lymph nodes and organs in Bulgarien patients with colorectal carcinoma. 2018; 2048: 020014 doi: 10.1063/1.5082032
|
| 46 |
Fiona R. Kolbinger, Johanna Kirchberg, Jürgen Weitz, Johannes Fritzmann. Optimale Therapiesequenz beim synchron hepatisch metastasierten kolorektalen Karzinom. coloproctology 2022; 44(4): 235 doi: 10.1007/s00053-022-00624-x
|
| 47 |
Ioannis D. Xynos, Nicolaos Kavantzas, Smaro Tsaousi, Michalis Zacharakis, George Agrogiannis, Christos Kosmas, Andreas Lazaris, John Sarantonis, Stavros Sougioultzis, Dimitrios Tzivras, Aris Polyzos, Efstratios S. Patsouris, Nikolas Tsavaris. Factors Influencing Survival in Stage IV Colorectal Cancer: The Influence of DNA Ploidy. ISRN Gastroenterology 2013; 2013: 1 doi: 10.1155/2013/490578
|
| 48 |
Shamin Azwar, Chin Tat Ng, Siti Yazmin Zahari Sham, Heng Fong Seow, Minhian Chai, Mohd Faizal Ghazali, Mohd Faisal Jabar. Possible Involvement of Long Non-Coding RNAs GNAS-AS1 and MIR205HG in the Modulation of 5-Fluorouracil Chemosensitivity in Colon Cancer Cells through Increased Extracellular Release of Exosomes. Non-Coding RNA 2024; 10(2): 25 doi: 10.3390/ncrna10020025
|
| 49 |
Yong-Hwi Kang, Jing-Hua Wang, Jin-Seok Lee, Nam-Hun Lee, Chang-Gue Son. Coptidis Rhizoma Suppresses Metastatic Behavior by Inhibiting TGF-β-Mediated Epithelial-Mesenchymal Transition in 5-FU-Resistant HCT116 Cells. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.909331
|
| 50 |
Silke Cameron, Diana Hünerbein, Tümen Mansuroglu, Thomas Armbrust, Jens-Gerd Scharf, Harald Schwörer, László Füzesi, Giuliano Ramadori. Response of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapy. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-218
|
| 51 |
Jesús García-Foncillas, Eduardo Díaz-Rubio. Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome. Clinical and Translational Oncology 2010; 12(8): 533 doi: 10.1007/s12094-010-0551-3
|
| 52 |
Chenbo Ding, Longmei Li, Taoyu Yang, Xiaobo Fan, Guoqiu Wu. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2834-8
|
| 53 |
T Matsumura, K Sugimachi, H Iinuma, Y Takahashi, J Kurashige, G Sawada, M Ueda, R Uchi, H Ueo, Y Takano, Y Shinden, H Eguchi, H Yamamoto, Y Doki, M Mori, T Ochiya, K Mimori. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. British Journal of Cancer 2015; 113(2): 275 doi: 10.1038/bjc.2015.201
|
| 54 |
Anna-Lena Mueller, Aranka Brockmueller, Niusha Fahimi, Tahere Ghotbi, Sara Hashemi, Sadaf Sadri, Negar Khorshidi, Ajaikumar B. Kunnumakkara, Mehdi Shakibaei. Bacteria-Mediated Modulatory Strategies for Colorectal Cancer Treatment. Biomedicines 2022; 10(4): 832 doi: 10.3390/biomedicines10040832
|
| 55 |
Terence C. Chua, Akshat Saxena, Winston Liauw, Francis Chu, David L. Morris. Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases – A systematic review. European Journal of Cancer 2012; 48(12): 1757 doi: 10.1016/j.ejca.2011.10.034
|